Forms and Clinical Studies

The resources below are meant to provide our members with additional information, education, and other means of assistance to you, your practice, and your patient families regarding their dietary management.

Forms and Resources

  • Insurance Forms

    The cost of an allergy-specific formula might be offset by insurance, so share this form with parents.

  • Reimbursement Code Resource

    When using this information, please note the following: Coding systems and reimbursement allowable rates vary by payer. Medicare Part B uses HCPCS (Healthcare Common Procedure Coding System) to group products. Medicaid systems vary by state; some use HCPCS while others use Product Reimbursement Codes or systems of their own. Contact your state provider for more information. Private health insurance and managed care companies may use HCPCS, Product Reimbursement Codes, or their own system. Contact your provider for more information.

    Reimbursement Information

  • Pediatric Perspectives Newsletter

    This special edition of the Pediatric Perspectives Newsletter includes reimbursement information.

Clinical Studies

  • Lactobacillus GG Improves Recovery in Infants with Blood in the Stools and Presumptive Allergic Colitis Compared with Extensively Hydrolyzed Formula Alone

    This clinical study shows the addition of LGG helps manage infants with CMPA.

  • Effect of Lactobacillus GG on tolerance acquisition in infants with cow’s milk allergy: A randomized trial

    See how after 12 months of consuming Nutramigen LGG, 81 percent of the babies with CMPA in this study built tolerance to cow’s milk protein.

  • With Nutramigen LGG, families can spend less time worrying about CMA

    Formula with LGG for management CMPA in infants influences tolerance, per this independent multicenter study.

  • Hypoallergenicity and Effects on Growth and Tolerance of a New Amino Acid-Based Formula with Docosahexaenoic Acid and Arachidonic Acid

    A study to compare the effect on growth in healthy infants of a new amino acid–based formula (AAF) and a control extensively hydrolyzed formula (EHF), with both docosahexaenoic acid (DHA) and arachidonic acid (ARA) at levels similar to those in human milk worldwide. In study 2, to evaluate the hypoallergenicity of this new AAF in infants and children with confirmed cow’s milk allergy (CMA).

  • Supporting Another Key Milestone

    DHA is proven to improve sustained attention in infants.

  • AAP Reflux Management Guidance - Gastroesophageal Reflux: Management Guidance for the Pediatrician, from the American Academy of Pediatrics

    Vanderhoof - Efficacy of a pre-thickened infant formula: a multicenter, double-blind, randomized, placebo-controlled parallel group trial in 104 infants with symptomatic gastroesophageal reflux.

    A study to evaluate a pre-thickened formula (Enfamil A.R.) for regurgitant gastroesophageal refllux, 104 infants were enrolled in a 5-week, multicenter, double-blind, randomized, placebo-controlled parallel group trial.